PET/CT Imaging of Malignant Brain Tumors With 124I-NM404

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 17, 2016

Study Completion Date

May 17, 2016

Conditions
GlioblastomaBrain Metastases
Interventions
DRUG

NM404

injection of either 2.0mCi or 5.0mCi I-124 NM404

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT01516905 - PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 | Biotech Hunter | Biotech Hunter